AP Pharma’s APF530 contains the 5-HT3 antagonist, granisetron, formulated in the company’s proprietary Biochronomer drug delivery system, which allows therapeutic drug levels to be maintained for five days
Both Affinity and JSW are expected to continue to offer their products and services under strict quality control measurements which meet government and regulatory requirements such as FDA,
Reportedly, the safety and efficacy of Carbaglu was studied in 23 patients with NAGS who received the treatment for times ranging from six months to 21 years. In
BioGaia already has agreements with Ferring Pharmaceuticals covering some ten countries in Latin America, where Mexico was the first country to launch the products. In Argentina the regulatory
Ovaprene is a ‘one-size-fits-all’ patented, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period. Reportedly, a Phase
Somaxon Pharma has said that Silenor has not been designated as a controlled substance by the US Drug Enforcement Administration (DEA) because of its demonstrated lack of abuse
Tepadina can be used to treat haematological diseases such as leukaemia, lymphoma, multiple myeloma and thalassemia and also specific solid tumours (eg breast cancer, CNS tumours, ovarian cancer
Competact is a fixed-dose combination tablet of pioglitazone hydrochloride with immediate release metformin hydrochloride. After reviewing its options Takeda has also decided to discontinue the development of the
Reportedly, Dicon has also shown to be effective in the treatment of irritable bowel syndrome (IBS). Ram Biotech said that Dicon’s combination herbal therapy (CHT) distinguishes it from
The trial will assess the safety, tolerability and efficacy of Stemedica’s high potency allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke. The
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.